Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chubb
US Army
Colorcon
McKesson
Boehringer Ingelheim
UBS
Federal Trade Commission
US Department of Justice
Dow
Cerilliant

Generated: October 21, 2017

DrugPatentWatch Database Preview

Promius Pharma Company Profile

« Back to Dashboard

What is the competitive landscape for PROMIUS PHARMA, and when can generic versions of PROMIUS PHARMA drugs launch?

PROMIUS PHARMA has five approved drugs.

There are four US patents protecting PROMIUS PHARMA drugs.

There are five patent family members on PROMIUS PHARMA drugs in four countries.

Summary for Applicant: Promius Pharma

International Patents:5
US Patents:4
Tradenames:5
Ingredients:5
NDAs:5
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Promius Pharma
TENEX
guanfacine hydrochloride
TABLET;ORAL019032-001Oct 27, 1986ABRXYesNo► Subscribe► Subscribe► Subscribe
Promius Pharma
SECTRAL
acebutolol hydrochloride
CAPSULE;ORAL018917-003Dec 28, 1984ABRXYesYes► Subscribe► Subscribe► Subscribe
Promius Pharma
ISMO
isosorbide mononitrate
TABLET;ORAL019091-001Dec 30, 1991DISCNNoNo► Subscribe► Subscribe► Subscribe
Promius Pharma Llc
CLODERM
clocortolone pivalate
CREAM;TOPICAL017765-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Promius Pharma
SECTRAL
acebutolol hydrochloride
CAPSULE;ORAL018917-001Dec 28, 1984ABRXYesNo► Subscribe► Subscribe► Subscribe
Promius Pharma Llc
SERNIVO
betamethasone dipropionate
SPRAY;TOPICAL208079-001Feb 5, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Promius Pharma Llc
SERNIVO
betamethasone dipropionate
SPRAY;TOPICAL208079-001Feb 5, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Promius Pharma Llc
SERNIVO
betamethasone dipropionate
SPRAY;TOPICAL208079-001Feb 5, 2016RXYesYes► Subscribe► SubscribeY ► Subscribe
Promius Pharma
TENEX
guanfacine hydrochloride
TABLET;ORAL019032-003Nov 7, 1988DISCNNoNo► Subscribe► Subscribe► Subscribe
Promius Pharma Llc
SERNIVO
betamethasone dipropionate
SPRAY;TOPICAL208079-001Feb 5, 2016RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Promius Pharma

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Promius Pharma
TENEX
guanfacine hydrochloride
TABLET;ORAL019032-001Oct 27, 1986► Subscribe► Subscribe
Promius Pharma
SECTRAL
acebutolol hydrochloride
CAPSULE;ORAL018917-001Dec 28, 1984► Subscribe► Subscribe
Promius Pharma
SECTRAL
acebutolol hydrochloride
CAPSULE;ORAL018917-003Dec 28, 1984► Subscribe► Subscribe
Promius Pharma
SECTRAL
acebutolol hydrochloride
CAPSULE;ORAL018917-003Dec 28, 1984► Subscribe► Subscribe
Promius Pharma
TENEX
guanfacine hydrochloride
TABLET;ORAL019032-002Nov 7, 1988► Subscribe► Subscribe
Promius Pharma
SECTRAL
acebutolol hydrochloride
CAPSULE;ORAL018917-001Dec 28, 1984► Subscribe► Subscribe
Promius Pharma
TENEX
guanfacine hydrochloride
TABLET;ORAL019032-003Nov 7, 1988► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Promius Pharma

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
9,775,851Topical formulations comprising a steroid► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Promius Pharma Drugs

Country Document Number Estimated Expiration
Japan2013503203► Subscribe
Denmark2473161► Subscribe
European Patent Office2473161► Subscribe
World Intellectual Property Organization (WIPO)2011026076► Subscribe
European Patent Office3141246► Subscribe
Japan5833007► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Merck
Covington
Colorcon
Johnson and Johnson
McKesson
US Army
Boehringer Ingelheim
AstraZeneca
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot